Ki Wan Park

Dr. Ki Wan Park

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KPKi Wan Park
Ki Wan Park
PKPeter John Kullar
Peter John Kullar
CMCharvi Malhotra
Charvi Malhotra
KSKonstantina Stankovic
Konstantina Stankovic
Importance: Chronic subjective tinnitus, the perception of sound without an external source for longer than six months, may be a greatly debilitating condition for some people, and is associated with psychiatric comorbidities and high healthcare costs. Current treatments are not beneficial for all patients and there is a large need for new therapies for tinnitus. Observations: Unlike rarer cases of objective tinnitus, chronic subjective tinnitus often has no obvious etiology and a diverse pathophysiology. In the absence of objective testing, diagnosis is heavily based on clinical assessment. Management strategies include hearing aids, sound masking, tinnitus retraining therapy, cognitive behavioral therapy, and emerging therapies including transcranial magnetic stimulation and electrical stimulation. Conclusions and relevance: Although current treatments are limited, emerging diagnostics and treatments provide promising avenues for the management of tinnitus symptoms.

5 March 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
KPKi Wan Park
Ki Wan Park
YCYi Cai
Yi Cai
TBTania Benjamin
Tania Benjamin
AQAmir Qorbani
Amir Qorbani
JGJonathan George
Jonathan George

8 September 2020 in Case Reports in Otolaryngology
Verified
Journal Article
Open access
PDF file
KPKi Wan Park
Ki Wan Park
AHAlbert Y. Han
Albert Y. Han
CKChristine M. Kim
Christine M. Kim
KTKenric Tam
Kenric Tam
DCDinesh K. Chhetri
Dinesh K. Chhetri
Contrast-induced sialadenitis (CIS) is a rare, delayed pseudoallergic reaction from iodine containing contrast. Previously reported cases of CIS demonstrated that the two major salivary glands (parotid and submandibular) can be affected. The initial encounter of this entity can raise alarms to physicians as the differential diagnoses include serious infectious and inflammatory conditions such as Ludwig’s angina and angioedema. Subsequently, it may lead to unnecessary testing and increased healthcare cost. Here we present a 60-year-old male who presented with bilateral sublingual gland swelling following exposure to iodinated contrast. With timely diagnosis by the otolaryngologist, the patient received conservative management that led to a full resolution within a few days. To date, this is the first case of CIS only involving the sublingual glands. We conclude that CIS can involve any of the major salivary glands.

24 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
JLJacklyn Liu
Jacklyn Liu
YTYoko Takahashi
Yoko Takahashi
URUmar Rehman
Umar Rehman
MTMario Turri-Zanoni
Mario Turri-Zanoni
Davide MattavelliDavide Mattavelli
Davide Mattavelli
MLMatt Lechner.
Matt Lechner.
Background: Sinonasal undifferentiated carcinoma (SNUC) is an extremely rare, high-grade, and aggressive tumor of the sinonasal tract. Due to the rarity of this malignancy, current treatment guidelines are based on small and often/mainly single-center retrospective datasets. In the absence of a universally accepted standard of care for SNUC, treatment approaches vary across countries and institutions, reflecting real-world clinical practice. The primary aim of this study was to describe real-world treatment and outcomes for patients with confirmed SNUC. Methods: This was an international, multi-center, retrospective, observational cohort study that pooled patients into the largest SNUC dataset to date. Fifteen centers were enrolled to contribute data, including seven from Europe, four from the United States, three from the United Kingdom, and one from Canada. In the absence of a universally accepted standard of care for SNUC, treatment approaches varied across countries and institutions, reflecting real-world clinical practice. Patients included were those with histologically confirmed SNUC who were treated between 1997 and 2021. Results: This study yielded 485 patients treated for SNUC. The median age at diagnosis was 55.6 years (IQR: 44.5–67.6), and 63.7% were male. Most cases presented at advanced stages, with 70.8% as T4a or T4b. Overall survival (OS) outcomes were available for 412 patients, with a median follow-up of 26.0 months. The 5- and 10-year OS were 47.2% (95% CI: 40.8–53.3%) and 39.6% (95% CI: 32.5–46.6%), respectively. Advanced age, dichotomized T-stage (T4a/b vs. T1–3), M-stage, and orbital involvement were significant poor prognostic factors on univariable analysis (p’s < 0.01). On multivariable analysis, orbital involvement (HR: 2.73, 95% CI: 1.42–5.27, p = 0.003) and distance metastasis stage (HR: 3.00, 95% CI: 1.25–7.21, p = 0.014) were both independently associated with worse OS. Conclusions: This observational study presents the largest multi-center cohort analysis of SNUC to date, providing new insights into prognostic factors for a rare cancer treated at global centers of excellence. Orbital involvement and the presence of metastases are candidate independent risk factors associated with poorer OS.

30 April 2026 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
EWEmily C. Woods
Emily C. Woods
TUTulsi Upadhyay
Tulsi Upadhyay
KPKi Wan Park
Ki Wan Park
SSShih‐Po Su
Shih‐Po Su
ZXZhen Xiao
Zhen Xiao
MBMatthew Bogyo
Matthew Bogyo

7 November 2025 in Otology & Neurotology
Verified
Journal Article
Closed access
KPKi Wan Park
Ki Wan Park
DPDaniel Penaranda
Daniel Penaranda
MNMark S. Nyaeme
Mark S. Nyaeme
KCKay W. Chang
Kay W. Chang
NBNikolas H. Blevins
Nikolas H. Blevins
TVTulio A. Valdez
Tulio A. Valdez
Objective: To evaluate the ability to distinguish cholesteatoma from surrounding tissues using autofluorescence intraoperatively. Study design: Prospective cohort study. Setting: Tertiary referral center. Patients: Patients with cholesteatoma undergoing middle ear surgery. Intervention: Autofluorescence imaging with 470 nm excitation light. Main outcome measure: Compare cholesteatoma autofluorescence with surrounding mucosa, bone, and granulation tissue. Results: A total of 6 patients undergoing cholesteatoma surgery were prospectively enrolled in the study for imaging. A custom-designed endoscopic and macroscopic imaging set-up utilizing 470 nm excitation was used to image the surgical field in real-time. Intraoperatively, autofluorescence imaging allowed delineation of cholesteatoma from surrounding bone, granulation tissue, and mucosa, even when cholesteatoma identification was difficult with white light alone. The 470 nm excitation was able to target endogenous fluorophores, specifically flavin adenine dinucleotide (FAD) and keratin, which are present within cholesteatoma, but not present in mucosa and granulation tissue. Conclusion: This study demonstrates the feasibility of autofluorescence-guided identification of cholesteatoma intraoperatively. The results support its potential as an adjunctive tool to surgeons for cholesteatoma identification.